BioCentury
ARTICLE | Company News

Delphi Genetics, Merck deal

October 15, 2012 7:00 AM UTC

Delphi granted Merck a non-exclusive license to use StabyExpress technology for protein expression in research and product development. Delphi is eligible to receive development milestone and royaltie...